News Archive - Urolink

NICE approves use of new treatment for advanced metastatic bladder cancer

Enfortumab Vedotin combined with Pembrolizumab will now be available for eligible patients in the UK

The British Association of Urological Surgeons (BAUS) welcomes the decision by the National Institute for Health and Care Excellence (NICE) to approve the use of combination therapy enfortumab vedotin (Padcev) with pembrolizumab as a first-line... Read more

22 Aug 2025

BAUS Launches "Check In, Don't Check Out" Awareness Campaign

Surgeons urge men to prioritise their health during Men’s Health Awareness Week (10 – 16 June)

The majority of UK men would rather chat about things like the British weather or politics than have a potential life-saving conversation with a GP around their urological health. Data released today (Monday 9 June) indicates that nearly a... Read more

9 Jun 2025